Dr. Marco Valgimigli and Dr. C. Michael Gibson Discuss: MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients August 28, 2021 Disclosures: TBD
Dr. George Dangas and Dr. C. Michael Gibson Discuss: ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation August 28, 2021 Disclosures: TBD
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: ESC 2021 Wrap-Up – Friday, August 27 August 27, 2021 Disclosures: TBD
Dr. Axel Bauer and Dr. Yaz Daaboul Discuss: Implantable cardiac monitors in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced left ventricular ejection fraction – A randomized trial August 27, 2021 Disclosures: TBD
Dr. Stefan Anker and Dr. C. Michael Gibson Discuss: EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalizations in patients with heart failure with a preserved ejection fraction, with and without diabetes August 27, 2021 Disclosures: TBD
Dr. Johanne Silvain Presents: Ticagrelor versus Clopidogrel in Elective Percutaneous Coronary Intervention : The Alpheus Trial July 30, 2021
Dr. Arnoud van ’t Hof, Dr. Jur ten Berg and Dr. C. Michael Gibson Discuss: A novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients May 18, 2021 Disclosures: TBD
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: ACC 2021 Wrap-Up – May 17, 2021 May 17, 2021 Disclosures: TBD
Dr. Birgit Vogel and Dr. C. Michael Gibson Discuss: Sex-Specific Outcomes In High-Risk Patients Receiving Ticagrelor With Or Without Aspirin After Percutaneous Coronary Intervention: Results From The Twilight Study May 17, 2021
Dr. Robert Rosenson and Dr. C. Michael Gibson Discuss: A Phase 2 Trial Of The Efficacy And Safety Of Evinacumab In Patients With Severe Hypertriglyceridemia May 15, 2021 Disclosures: TBD
